Sept. 7, 2022

Integrated Business Planning in Life Sciences – September 8, 2022

Integrated Business Planning in Life Sciences – September 8, 2022
Integrated Business Planning in Life Sciences – September 8, 2022
Trending Health
Integrated Business Planning in Life Sciences – September 8, 2022

To keep up with the ever-evolving healthcare landscape, it is critical for Life Science companies to identify ways to enhance and integrate business planning (IBP) across their operating functions. Mindy & Ryan are joined by Vynamic’s Dan Ahern and Owen Thomas to understand the why IBP is so important and explore how focusing on these processes can help organizations achieve their strategic and operational goals. The conversation begins with a detailed overview of IBP practices within Life Sciences organizations today (1:18), before transitioning into a broader conversation around the wide-reaching financial and efficiency gains if executed correctly (3:08). The group identifies key challenges that impact proper IBP planning processes, including supply chain disruptions and economic volatility (13:15). Finally, Dan and Owen discuss how organizations can anticipate and address these barriers by employing IBP best practices (16:08).

Podcast Tags: healthcare, healthcare news, Life Sciences, Business Planning, commercialization

Source Links:

· https://blogs.sap.com/2017/08/04/integrated-business-planning-for-the-life-science-industry/

· https://www.pwc.com/gx/en/pharma-life-sciences/pdf/pwc-integrated-rd-op-bus-plan.pdf

· https://www.fiercebiotech.com/biotech/vc-firms-biotechs-push-back-drug-pricing-reforms-would-render-small-molecule-drugs

· https://www.mckinsey.com/industries/life-sciences/our-insights/five-ways-that-life-science-companies-can-build-tech-talent

· https://www.mckinsey.com/industries/life-sciences/our-insights/pharma-operations-creating-the-workforce-of-the-future

· https://www2.deloitte.com/us/en/pages/regulatory/articles/life-sciences-regulatory-outlook.html

· https://www.mckinsey.com/industries/life-sciences/our-insights/reimagining-how-life-sciences-work-will-be-done-in-the-next-normal

· https://medium.com/the-slalom-daily-dose/case-study-how-did-a-global-life-sciences-company-transform-its-supply-chain-planning-processes-9bc322137a67

· https://www2.deloitte.com/content/dam/Deloitte/ch/Documents/life-sciences-health-care/deloitte-lshc-en-commercial-operations-in-life-sciences.pdf

· https://www2.deloitte.com/content/dam/Deloitte/global/Documents/Life-Sciences-Health-Care/gx-life-sciences-regulation-predictions-2025.pdf

For additional discussion, please contact us at TrendingHealth.com or share a voicemail at 1-888-VYNAMIC.

Mindy McGrath, Healthcare Industry Advisor

mindy.mcgrath@vynamic.com

Ryan Hummel, Executive and Head of Provider Sector

ryan.hummel@vynamic.com

Dan Ahern, Manager

dan.ahern@vynamic.com

Owen Thomas, Director

Owen.Thomas@vynamic.com